APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
51 hedge funds and large institutions have $207M invested in Aptose Biosciences, Inc. in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
-5
Holders Change %
-8.93%
% of All Funds
1.13%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.13%
New
17
Increased
18
Reduced
9
Closed
22
Calls
$578K
Puts
$1.3M
Net Calls
-$723K
Net Calls Change
-$1.22M
Top Buyers
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$15.1M |
| 2 |
CA
Corriente Advisors
Fort Worth,
Texas
|
+$14.6M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$9.16M |
| 4 |
CCM
Consonance Capital Management
New York
|
+$6.08M |
| 5 |
Goldman Sachs
New York
|
+$3.88M |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5.73M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.51M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.37M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.65M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$3.45M |
